Institutional investors hold a majority ownership of CELG through the 84.61% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2013, these large investors purchased a net $2.0 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
AMUNDI SMITH BREEDEN LLC Bought 28.3 Thousand shares of Celgene Corp
STATE STREET GLOBAL ADVISORS FRA... Bought 26.0 Thousand shares of Celgene Corp